2 completed, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Oxygen-15: new trials by email Literature Review of Oxygen-15 trials Research Report on Oxygen-15
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Registering Genomics and Imaging of Tumors (ReGIT) FET F-18, O-15 Radioisotope, CT scan - Glioma | Recruiting | Indiana University | 20 | 2023-07-18 | 2025-09-15 | |
| Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders Non invasive VN stimulation (nVNS), Oxygen (15-O) Water, Sham Stimulation - Substance-Related Disorders, Substance Use Disorders | Phase 3 | Completed | Emory University | 20 | 2020-11-13 | 2023-09-13 |
| 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease 17 allylamino-17-demethoxygeldanamycin, 18 FDG (Fludeoxyglucose 18F), [15-O] H2O - Hippel-Lindau Disease, Kidney Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 9 | 2004-07-01 | 2012-07-27 |
Carcinoma, Renal Cell (1) · Glioblastoma (1) · Glioma (1) · Kidney Neoplasms (1) · Opioid-Related Disorders (1) · Substance Abuse, Intravenous (1) · Substance-Related Disorders (1) · von Hippel-Lindau Disease (1)
Emory University (1) · Indiana University (1) · National Cancer Institute (NCI) (1)
United States (3)
J Douglas Bremner, MD (1) · Jason Parker, PhD (1) · William M Linehan, M.D. (1)
UG3DA048502 (1)